Aktiesnakken — April 2020
-
Vi krydser alt det som krydses kan.
-
Novos orale diabetesmiddel godkendt i EU
Rybelsus (oral semaglutid) fra Novo Nordisk har fået markedsføringstilladelse af Europa-Kommissionen til voksne, med dårligt kontrolleret blodsukker som et supplement til diæt og motion.
(medicinsktidsskrift.dk)
-
Novo
-
Er jeg bare bagud?
-
Kun 1 dag, Novo sendte meddelelse ud i går...
-
@GeorgeBest - ok. Nu til dags er jeg jo så uendelig langt bagud:-)
-
Men det er jo weekend;-)
-
Olie starter 10% nede
-
Kæmpe fald i antal smittede det sidste døgn ned fra 101.500 til 74.700.
-
Det ser bemaerkelsesvaerdigt ud, kan det have indvirken det var soendag?
-
Nikkei 225 i Tokyo klatrer 2,41 prosent
Hang Seng i Hongkong stiger 0,88 prosent
Kospi i Seoul klatrer 2,12 prosent
Singapore-børsen stiger 1,93 prosent
ASX 200 i Sydney hopper 3,09 prosent -
Holger Zschaepitz
@Schuldensuehner
·
9 min
Global markets start the week in Risk-On mode on Virus slowdown hopes. US & European Futures jump 4%, Japan’s Nikkei ended 4.2% higher. Brent oil turns pos >$34/bbl after hints that Russia & Saudi Arabia close to deal. Bonds drop w/US 10y yields at 0.63%. Gold 1625, Bitcoin >$7k. -
God morgen
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind